Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitors.

The upregulation of pteridine reductase (PTR1) is a major contributor to antifolate drug resistance in Leishmania spp., as it provides a salvage pathway that bypasses dihydrofolate reductase (DHFR) inhibition. The structure-based optimization of the PTR1 inhibitor methyl-1-[4-(2,4-diaminopteridin-6-ylmethylamino)benzoyl]piperidine-4-carboxylate (1) led to the synthesis of a focused compound library which showed significantly improved selectivity for the parasite's folate-dependent enzyme. When used in combination with pyrimethamine, a DHFR inhibitor, a synergistic effect was observed for compound 5b. This work represents a step forward in the identification of effective antileishmania agents.

[1]  M. Day,et al.  One Health: The global challenge of epidemic and endemic leishmaniasis , 2011, Parasites & Vectors.

[2]  Maria Paola Costi,et al.  Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase. , 2011, Journal of medicinal chemistry.

[3]  A. Fairlamb,et al.  Trypanosoma brucei pteridine reductase 1 is essential for survival in vitro and for virulence in mice , 2010, Molecular microbiology.

[4]  P. Ready.  Leishmaniasis emergence in Europe. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  N. Schormann,et al.  Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate. , 2009, Acta crystallographica. Section D, Biological crystallography.

[6]  Maria Paola Costi,et al.  Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development , 2008, Proceedings of the National Academy of Sciences.

[7]  Ting-Chao Chou,et al.  Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.

[8]  K. Stengele,et al.  New Types of Very Efficient Photolabile Protecting Groups Based upon the [2-(2-Nitrophenyl)propoxy]carbonyl (NPPOC) Moiety , 2004 .

[9]  S. Beverley,et al.  Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy. , 2001, Molecular and biochemical parasitology.

[10]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[11]  Ian H. Gilbert,et al.  Dihydrofolate reductase: A potential drug target in trypanosomes and leishmania , 1998, J. Comput. Aided Mol. Des..

[12]  David A. Matthews,et al.  Structure of and kinetic channelling in bifunctional dihydrofolate reductase–thymidylate synthase , 1994, Nature Structural Biology.

[13]  M. Ouellette,et al.  A novel antifolate resistance gene on the amplified H circle of Leishmania. , 1992, The EMBO journal.

[14]  T. Harris,et al.  Synthesis of DL-slaframine , 1984 .

[15]  R. Brun,et al.  Cultivation and in vitro cloning or procyclic culture forms of Trypanosoma brucei in a semi-defined medium. Short communication. , 1979, Acta tropica.

[16]  J. Montgomery,et al.  Preparation of 6-(bromomethyl)-2,4-pteridinediamine hydrobromide and its use in improved syntheses of methotrexate and related compounds. , 1977, The Journal of organic chemistry.

[17]  I. H. Segel.  Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems , 1975 .

[18]  R. Riemschneider,et al.  Acylderivate cyclischer Verbindungen, V. Zur Herstellung von o‐Diacetyl‐benzol und 4‐Nitro‐1.2‐diacetyl‐benzol , 1959 .

[19]  D Steverding,et al.  A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue. , 2000, Parasitology international.